Some lung cancers manage to overcome a targeted drug therapy despite it showing initial success. Yale researchers have now discovered a molecular-level resistance mechanism that begins to take hold as early as six to eight weeks after the cancer…
Continue Reading
News Source: medicalxpress.com
Leave a Reply